. The stereospecificity pattern for UTP analog recognition was UMP Ͼ UDP Ն ADP ϭ UTP ϭ dTTP Ͼ adenosine 5Ј-O-(3-thiotriphosphate) ϭ ATP ϭ CTP ϭ 2Ј-and 3Ј-O-4-(benzoylbenzoyl)-ATP (Bz-ATP) Ն AMP Ն 2-methylthio-ATP ϭ ␣,␤-methylene-ATP Ͼ uridine ϭ diadenosine tetraphosphate (Ap 4 A); cAMP and adenosine were inactive. Antagonist recognition pattern was DIDS ϭ pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS) ϭ reactive blue 2 Ͼ suramin. The rank order of potencies for agonist-induced PLC activation was UDP Ն UTP Ն Ap 4 A Ն UMP ϭ Bz-ATP; uridine was inactive. UTP-stimulated PLC activity was inhibited by DIDS ϭ reactive blue 2 ϭ PPADS Ͼ suramin. These results suggest that the population of [ 3 H]UTP-labeled binding sites is heterogeneous, with a low number of high-affinity UTP receptors whose function(s) need to be determined and a large number of moderateaffinity receptors triggering PLC activation. inner ear; 3 H-labeled uridine 5Ј-triphosphate binding; P2(Y) receptors; nucleotide analogs THE MEMBRANOUS LABYRINTH separates two fluids of differing composition. The luminal compartment is filled with endolymph, a K ϩ -rich, Na ϩ -low, and hyperosmotic fluid, whereas the surrounding spaces are filled with perilymph whose composition resembles that of an extracellular fluid, and a positive transepithelial potential is recorded between the endolymphatic and perilymphatic compartments. Both the high K ϩ concentration of the endolymph and the positive transepithelial potential are involved in the transduction mechanisms at the apical side of the sensory cells. Endolymph composition is maintained by a K ϩ transport localized in nonsensory epithelia of the inner ear, i.e., the dark cells in the vestibule and the strial marginal cells in the cochlea (for review, see Ref. 27) .
Evidence has been provided for regulating roles of extracellular ATP and UTP on both neurotransmission and endolymph homeostasis in inner ear organs (2, 22, 28) . ATP has been found in perilymphatic and endolymphatic fluids of the cochlea (24) , and it regulates the transduction processes of sound and motion stimuli and controls the functions of the secretory epithelial cells (20, 28) . For UTP actions, a UTP-sensitive phosphoinositidase C activity has been identified in ampulla from Rana ridibunda semicircular canal (6) and it was reported that UTP decreases the vectorial transport of K ϩ toward the endolymphatic space in the gerbil vestibule and cochlea (20) . It has been assumed that the phosphoinositidase C stimulation after UTPsensitive P2(Y) receptor occupancy triggers direct activation of protein kinase C through diacylglyceroldependent and inositol trisphosphate-and Ca 2ϩ -independent mechanisms (22, 23) .
The aim of the present work was to characterize the pharmacological properties of the pyrimidine nucleotide-sensitive P2(Y) receptors expressed in ampulla of R. ridibunda semicircular canal by making direct [ 3 H]UTP binding experiments on single ampullas isolated by microdissection and screening the abilities of unlabeled structural nucleotide analogs more specific for the P2(X) ligand-gated ion channels or P2(Y) receptors linked to G protein signal pathways (13, 14) to inhibit radioligand binding and to stimulate phosphoinositidase C in myo-[ 3 H]inositol-loaded ampullas. The binding study was based on previous findings performed on rat lung membranes demonstrating that [ 3 H]UTP-labeled membranous binding sites recognize specifically pyrimidine nucleotides (17) . Our results suggest that the population of ampullary [ 3 H]UTP-labeled binding sites is heterogeneous and contains a minor class of high-affinity UTP binding sites whose functions remain to be determined and a major class of P2(Y)-like receptors exhibiting moderate affinity for UTP and triggering phosphoinositidase C activation. Other chemicals were provided from the following sources: adenosine, AMP, cAMP, ADP, ATP, adenosine 5Ј-O-(3-thiotriphosphate) (ATP␥S), 2Ј-and 3Ј-O-4-(benzoylbenzoyl)-ATP (Bz-ATP), ␣,␤-methylene-ATP (␣,␤-Me-ATP), diadenosine tetraphosphate (Ap 4 A), cytidine, CTP, dTTP, UMP, UDP, UTP, bacitracin, BSA, DIDS, reactive blue 2 (basilen blue E-3G), Coomassie blue, ouabain, and sodium azide from Sigma (St. Louis, MO); pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS), and 2-methylthio-ATP (2-MeS-ATP) from Research Biochemicals International (Natick, MA); suramin from Miles (Naperville, IL); hexokinase, creatine kinase, and creatine phosphate from Boehringer (Mannheim, Germany); urethan from Prolabo (Paris, France); and Dowex resin AG 1 -X 8 (200-400 mesh, formate form) from Bio-Rad Laboratories (Richmond, CA).
MATERIALS AND METHODS

Products Used
Animals
Experiments were performed using adult frogs of both sexes of the species R. ridibunda purchased from the Ardenay Breeding Center (France). Frogs were kept in tanks containing tap water at 8°C. After percutaneous anesthesia with urethan, they were decapitated. The head was split in two halves, and the brain was destroyed (approval of the Ministère de lЈAgriculture et de la Pêche, no. 5521).
Microdissection of Ampullas from Frog Semicircular Canals
Microdissection of the three semicircular canals from each inner ear was performed under stereomicroscopic observation in a chilled modified amphibian Ringer solution, medium A (in mM: 20 HEPES-NaOH, pH 7.5, 82 NaCl, 3 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 0.33 Na 2 HPO 4 , 0.44 NaH 2 PO 4 , 5 glucose, 10 sodium acetate, and 0.1% BSA). The ampullas were separated from the adjacent regions of the semicircular canals and opened by sagittal incision of their dorsal levels. 
H]UTP Binding Studies
Binding assays. Assays were performed using a microtechnique reported earlier with slight modifications (7). Ampullas were first washed at 4°C in a large volume of medium B devoid of divalent cations (in mM: 40 HEPES-NaOH, pH 7.5; 0.25 EDTA-NaOH, pH 7.5; 82 NaCl, 3 KCl, 0.33 Na 2 HPO 4 , 0.44 NaH 2 PO 4 , 5 glucose, and 10 sodium acetate). For each single determination, one ampulla was transferred onto a 10-l droplet of medium C (medium B containing 0.1 mM ouabain, 10 mM sodium azide, 50 nM [ 3 H]UTP, and various amounts of unlabeled UTP analogs or antagonists) put on the hollow of a siliconized bacteriological slide, and samples were tightly covered with a petroleum jelly-coated slide to obtain a watertight seal. The binding reaction was carried out for 4 h at 4°C and stopped by adding 200 l chilled medium B. The tissue sample was removed, washed five times in 200 l of medium B at 4°C, and a 5-l droplet containing the ampulla was sucked out from the last rinse, whereas an equivalent volume of this rinse was used as blank reference (the duration of washing was ϳ1 min). Then, samples were treated with 10 l 1 N NaOH and 200 l 30% Coomassie blue for protein content determinations using BSA as a standard. 
where RL is the specific binding measured; X, Y, and B are the radioactivities measured for total binding, nonspecific binding, and blank samples; P 1 and P 2 are the protein contents of ampullas used for total and nonspecific binding determinations, and SRA is the specific radioactivity of the radioligand. Binding capacities were expressed as 10
Kinetic parameters for binding of unlabeled structural UTP analogs and unrelated chemicals acting as antagonists in other systems (13, 32) were computed from results of competition experiments between 50 nM [ 3 H]UTP and increasing amounts of unlabeled analogs. The observed dosedependent inhibition binding curves are adequately accounted for by the following relation
where R T is the maximal binding capacity, L and I are the concentrations, K B and K I are the apparent dissociation constants (nucleotide concentration leading to half-maximal occupancy of specific binding sites), and nH and m are the Hill coefficients for binding of the radioligand and unlabeled analog, respectively. Experimental data were fitted according to the expected linear relationship
where RL 0 and RL are binding capacities observed in absence or presence of inhibitor. Slopes and x-intercepts of the plots give values of m and IC 50 (unlabeled analog concentration ensuring half-displacement of labeled binding sites). K I were further calculated from the equation 
It was assumed that the K B values for binding of unlabeled nucleotides and antagonists are equal to the corresponding K I values determined experimentally (7).
Phosphoinositidase C Studies
Enzymatic assays. Assays were performed using a microtechnique described earlier (6 3 H]inositol. The incubation was started by adding one ampulla in 100 l medium E (medium A containing 35 mM HEPES-NaOH, pH 7.5, 10 mM LiCl, 0.1% bacitracin, and various amounts of UTP or structural analogs) carried out at 26°C and stopped 30 min later by adding successively: 1 ml chloroform-methanol (1:2 vol/vol), 0.2 ml 5 mM EDTA-NaOH, pH 7.0, 0.3 ml chloroform, and 0.3 ml H 2 O at 4°C. Samples were centrifuged at 3,000 g for 5 min at 4°C, and the upper hydrophilic phases were removed for chromatography. Then, 0.5 ml methanol and 0.5 ml H 2 O were added to the remaining hydrophobic phases, and samples were centrifuged at 3,000 g for 5 min at 4°C. The resulting lower phases were recovered, transferred in counting vials, and evaporated to dryness before determinations of radioactivities incorporated in total (⌺) phosphoinositides.
Measurements of [ 3 H]inositol phosphates by anion exchange chromatography.
Radioactivities associated to free inositol, glycerophosphoinositol (GroPIns), and total inositol phosphates (⌺InsP s ) were separated as reported earlier (4) . Samples were applied to columns containing 0.25 g Dowex resin AG 1 -X 8 and free inositol, GroPIns, and InsP s were, respectively, eluted with 8 ml of the following solutions: 1) 3 mM HEPES-NaOH, pH 7.0, 2) 30 mM ammonium formate, and 3) 1 M ammonium formate and 0.1 M formic acid.
Calculations. Results were expressed as ratios between radioactivities measured in a given inositol-containing pool and in all labeled inositol-containing cellular pools (the latter was: 23,254 Ϯ 3,865 cpm/ampulla; means Ϯ SE of results from 19 independent experiments).
The kinetics of phosphoinositidase C activation induced by potent agonists are described by the following relation
where V and V max are enzyme activations (above basal velocity) measured in presence of submaximal and saturating agonist concentrations (L), K a and nH are the apparent activation constant (nucleotide concentration leading to halfmaximal enzyme activation) and Hill coefficient of the agonist. K a and nH were deduced from x-intercepts and slopes of Hill plots of dose-response curves. Intrinsic activities of agonists (i.e., magnitude of maximal enzyme activation) were expressed as ratios between phosphoinositidase C activations induced by saturating concentrations of a given agonist (⌬ max ) and of UTP (⌬ max UTP ) measured in the same experiment.
The kinetics of UTP-induced enzyme activation observed in the presence of competitive inhibitors are adequately accounted for by the following relation
where L and I are the concentrations of UTP and antagonist, ni is the Hill coefficient for UTP measured in presence of inhibitor, and K i and m are the apparent inhibition constant and Hill coefficient of the antagonist. Results of competition experiments performed using a constant amount of inhibitor and increasing concentrations of UTP were fitted in Hill coordinates, and slopes and x-intercepts of the plots give values of ni and of KЈ (UTP concentration leading to halfmaximal enzyme activation). Data of experiments performed using 5 M UTP and increasing amounts of antagonist were fitted according to the expected linear relationship
where V 0 and V are enzyme activations measured in absence or presence of inhibitor. Slopes of the plots give values of m. K i were further computed as follows
Control experiments. Accurate screening of receptor stereospecificity for recognition of structural UTP analogs could be hampered by impurities contained in commercial nucleotide preparations (18, 19) or by potential ectoenzyme-catalyzed interconversion between triphospho-and diphosphonucleotides (11, 12) . These ectonucleotidase activities have been shown to occur in guinea pig cochlea (29) . Thus control experiments were run to check the possible effects of an UTP contaminant on phosphoinositidase C response to UDP by pretreatment of 1 mM UDP with 10 IU/ml hexokinase and 25 mM glucose in medium A for 1 h at 37°C (18) and, conversely, to investigate the effects of a UTP-regenerating system (0.1% creatine kinase and 20 mM creatine phosphate) on UTPstimulated enzyme activity.
Statistical Analysis
Results were given as means Ϯ SE of n replicates (i.e., n independent samples, each containing 1 ampulla) performed in the same experiment or as means Ϯ SE of mean data from N different experiments.
Generally, for each experiment, six to eight concentrations of a given UTP analog were tested in five replicates. Therefore, each dose-dependent inhibition binding curve or dosedependent enzyme activation curve was drawn from data obtained with 30-40 ampullas microdissected from five to seven frogs.
For each analog tested, the 95% confidence interval variation range of pK B value for binding and of pK a value for agonist-induced phosphoinositidase C activation or pK i value for antagonist-induced inhibition of UTP-stimulated enzyme activity (pK B ϭ Ϫlog K B , pK a ϭ Ϫlog K a , and pK i ϭ Ϫlog K i in which K B , K a , and K i values are expressed as molar concentrations) were calculated by computerized analysis of the corresponding dose-dependent inhibition binding curves or dose-response curves (GraphPad Prism Software; sigmoidal dose-response fit with variable slope). It has been assumed at the 95% probability level that two analogs bind to ampullas, stimulate phosphoinositidase C, or inhibit UTPinduced enzyme activation with differing apparent affinities only when the lower limit of the pK B , pK a , and/or pK i variation range of the best nucleotide is higher than the upper limit of the pK B , pK a , and/or pK i variation range of the worst analog.
RESULTS
[ 3 H]UTP Binding Studies
Preliminary control experiments indicated that total and nonspecific binding of 50 nM [ 3 H]UTP to ampullas reached fairly steady-state levels within 2-3 h at 4°C (results not shown).
Ampullas isolated from frog semicircular canals bound specifically [ and 3.34 Ϯ 0.26 fmol [
3 H]UTP bound/g protein (means Ϯ SE of mean data from 33 independent experiments).
Results depicted in Fig. 1 summarize the main characteristics of UTP binding to frog ampullas measured under equilibrium conditions. Specific binding of The stereospecificity of labeled binding sites for recognition of a series of unlabeled structural UTP analogs and antagonists was assessed on the basis of competition experiments similar to those illustrated in Fig. 2 , and all results are summarized in Table 1 . Data demonstrate that most of the drugs tested inhibited 
Phosphoinositidase C Studies
In line with previously published data (6), results depicted in Fig. 3 show that the incubation of labeled myo-[ N ϭ 19) . Data indicate also that for each UTP concentration tested, the increase in radioactivity associated with InsP s was accompanied by an equivalent decrease of radioactivity in total phosphoinositides, whereas no marked changes occurred for free-labeled inositol, and UTP did not stimulate GroPIns production. In addition, similar results were obtained for all potent nucleotides tested (data not shown).
Results summarized in Table 2 illustrate the sensitivity of phosphoinositidase C to structural UTP analogs. It is worth noting that the nucleotides tested were able to stimulate phosphoinositidase C with differing potencies as regards 1) their apparent activation constants [K a values for UDP and UTP are far lower than those of UMP, the selective P2Y Ap 4 A agonist Ap 4 A (14), and the potent marker of P2X 7 receptors Bz-ATP], 2) their Hill coefficients (UTP and Ap 4 A stimulated enzyme activity with negative cooperativity phenomena, UDP, and Bz-ATP according to Michaelian kinetics, and UMP with slight positive cooperativity phenomena), and 3) their intrinsic activities or magnitude of the maximal responses observed (UMP and Bz-ATP exhibited partial agonistic potencies, whereas uridine was devoid of activity).
Data from a competition experiment between UMP and UTP [increases in 
-test).
These observations indicate that UMP and UTP stimulate the same pool of phosphoinositidase C with differing affinities.
As expected, chemicals revealing antagonistic potencies in other systems (13, 32) failed to increase basal InsP s production: the latter was not modified by 0.2 mM reactive blue 2, 0.5 mM DIDS, or 5 mM PPADS and was decreased by ϳ50% in presence of 10 mM suramin (results not shown). The four antagonists tested inhibited UTP-induced phosphoinositidase C activation according to pure competitive inhibition kinet- ics (Fig. 4 and Table 2 ). They increased the UTP concentration leading to half-maximal enzyme activation, did not reduce the maximal enzyme activation, and diminished in a dose-dependent and saturable fashion the enzyme response to 5 M UTP either with negative cooperativity phenomena (DIDS and PPADS), according to Michaelian kinetics (reactive blue 2), or with slight positive cooperativity phenomena (suramin). In addition, reactive blue 2, DIDS, and PPADS enhanced the Hill coefficient for UTP-stimulated InsP s production; ni values (see Eq. 7) were, respectively, 0.8, 1.2, and 1.3 for UTP-induced enzyme activations measured in presence of 0.2 mM reactive blue 2, 0.5 mM DIDS, and 5 mM PPADS, whereas ni was equal to 0.6 in presence of 10 mM suramin.
Finally, data from control experiments show that the pretreatment of UDP with hexokinase did not modify kinetic parameters for UDP-induced phosphoinositidase C stimulation. Apparent activation constants and Hill coefficients were K a ϭ 0.61 and 0.56 M, and nH ϭ 0.90 and 1.01 for control and hexokinase-treated samples, respectively. Indeed, fitting basal, submaximal, and maximal UDP-stimulated enzyme activities of hexokinase-treated samples against the corresponding activities of control samples generated a linear plot (y ϭ 1.08x ϩ 0.17, r ϭ 0.97) whose slope and y-intercept do not differ, respectively, from unity and zero (P Ͻ 0.05; Student's t-test). In addition, the presence in the incubate of a UTP-regenerating system did not impair basal, 5 M UTP-, and 0.1 mM UTP-stimulated phosphoinositidase C activities. The corresponding [ 3 H]InsP s productions (% of total radioactivity found in all inositol-containing cellular pools; means Ϯ SE of 5 replicates) were 1.8 Ϯ 0.2 and 2.0 Ϯ 0.1 (basal), 7.9 Ϯ 0.9 and 8.3 Ϯ 1.2 (5 M UTP), and 9.8 Ϯ 1.0 and 10.9 Ϯ 0.7 (0.1 mM UTP) for samples assayed in absence or presence of the UTP-regenerating system, respectively.
DISCUSSION
The experiments described above provide evidence for the presence of specific binding sites for [ 3 H]UTP in ampulla from R. ridibunda semicircular canal and confirm the presence of a UTP-sensitive phosphoinositidase C system in this structure (6). Fig. 3 . Dose-dependent UTP-induced changes in labeled inositolcontaining cellular pools in ampullas from frog semicircular canals. Results were obtained in 1 experiment, and mean data from 5 independent experiments are summarized in Table 2 . Myo-[ 3 H]inositol-labeled ampullas were incubated for 30 min at 26°C with the indicated amounts of UTP before measurements of radioactivities incorporated in cellular free inositol, total (⌺) phosphoinositides, and total inositol phosphates (⌺InsP s ) and glycerophosphoinositol (GroPIns). Data (means Ϯ SE of 5 replicates performed in the same experiment) were expressed as % of total radioactivity found in all inositol-containing cellular pools. Arrow, UTP concentration leading to half-maximal activation of InsP s production. Apparent activation constant and Hill coefficient for UTP-induced enzyme activation were computed from x-intercept and slope of Hill plot of UTPstimulated InsP s reduction curve (y ϭ 0.52x ϩ 2.64, r ϭ 0.99). Values are mean data from 2 independent experiments. Apparent dissociation constants (K B ) for binding of unlabeled structural nucleotide analogs and antagonists are given in terms of pK B ϭ Ϫlog K B , in which K B values are expressed as molar concentration. For each chemical tested, the 95% confidence interval variation range of pK B value was calculated by computerized analysis of the corresponding binding curve (GraphPad Prism Software; sigmoidal dose-response fit with variable slope). It was assumed at the 95% probability level that 2 analogs bind with differing apparent affinities only when the lower limit of pK B variation range of the best analog is higher than the upper limit of pK B variation range of the worst analog. Computations give the following rank order of pK B values: Values are means Ϯ SE; values in parentheses are nos. of experiments. Apparent activation constants (K a ) for agonist-induced phosphoinositidase C activation and apparent inhibition constants (K i ) for antagonist-induced inhibition of UTP-stimulated enzyme activity are given in terms of pK a ϭ Ϫlog K a and pK i ϭ Ϫlog K i in which K a and K i values are expressed as molar concentration. For each analog tested, the 95% confidence interval variation range of pK a or pK i value was calculated by computerized analysis of the corresponding dose-response curve (see Table 1 legend). It was assumed at the 95% probability level that 2 analogs stimulate phosphoinositidase C (or inhibit UTP-induced enzyme activation) with differing apparent affinities only when the lower limit of pK a (or pK i ) variation range of the best analog is higher than the upper limit of pK a (or pK i ) variation range of the worst analog. Computations give the following rank order of stereospecificity: UDP Ն UTP Ն DIDS ϭ reactive blue 2 ϭ PPADS ϭ Ap 4 A Ն UMP ϭ Bz-ATP Ͼ suramin ϾϾϾ uridine. The lowest and highest r 2 values of the fits for calculations of 95% confidence intervals were 0.95 for Ap 4 A and Bz-ATP and 0.98 for UDP. ⌬ max /⌬ max UTP ; ratios between maximal enzyme activations induced by saturating concentrations of a given agonist and of UTP measured in the same experiment. Fig. 4 . Inhibition induced by DIDS of UTP-stimulated phosphoinositidase C activity in ampullas from frog semicircular canals. Results illustrated in A and B were obtained in separate experiments, and mean data from 2 sets of independent experiments are summarized in Table 2 . Myo-[ one hand, it should be stressed, that the maximal UTP binding capacity of frog ampulla was similar to those reported for binding of adenosine 5Ј-O-(2-thiodiphosphate) (ADP␤S) to the same structure (7) and to cultured bovine aortic endothelial cells (31) but was about two orders of magnitude higher than the density of ADP␤S receptors in avian erythrocyte membranes (10) and of UTP receptors in rat lung membranes (17) . On the other hand, it is worth noting that UTP bound to frog ampullas with an apparent dissociation constant close to that of ADP␤S (7) but higher than the K B values for UTP binding to rat lung membranes (17) and for ADP␤S binding to avian erythrocyte membranes and to cultured bovine aortic endothelial cells (10, 31) . Thus the discrepancies found between amphibia and higher vertebrates might reflect some zoological stereospecificities in nucleotide sensitivity of target cells, as observed earlier for neurohypophysial hormone binding to renal receptors from various amphibian and mammalian species (1, 5, 16) .
It seems unlikely that the differences observed between K B values for nucleotide bindings and between K a values for phosphoinositidase C stimulations resulted from ecto-ATPase and ecto-nucleotidase activities (11, 12, 29) because binding assays were performed under experimental conditions known to reduce enzymatic degradation of nucleotides, i.e., at 4°C and in absence of divalent cations (32, 33) , and the presence in the phosphoinositidase C assay medium of a triphosphonucleotide-regenerating system did not modify enzyme responses to UTP and ATP (6) . Moreover, the presence of contaminants in nucleotide preparations could hamper determinations of kinetic parameters for nucleotide binding and/or enzyme activation (17, 18) . However, the pretreatment of UDP with hexokinase did not impair K a and nH values for UDP-induced phosphoinositidase C stimulation. These results suggest that the differences found between pK B values for UDP and UTP binding and pK a values for UDP-and UTP-induced phosphoinositidase C activations could not result from contaminations of UDP by UTP.
Data of binding and phosphoinositidase C studies suggest strongly that the population of ampullary [ 3 H]UTP-labeled binding sites is heterogeneous because Scatchard plot of UTP binding may be analyzed as a combination of a minor class of high-affinity binding sites and a major class of moderate-affinity binding sites and no correlation occurs between the pK a (or pK i ) values of analogs for phosphoinositidase C activation [reported in this study and earlier (6)] and their corresponding pK B values for binding (y ϭ 0.33x ϩ 2.21, r ϭ 0.37; not significant). Among all chemicals tested, only the agonists UDP, ATP␥S, ATP, 2-MeS-ATP, and Ap 4 A and the antagonists DIDS, PPADS, and reactive blue 2 bound to ampullas, stimulated InsP s production, and/or inhibited UTP-induced phosphoinositidase C activation with similar apparent affinities. Moreover, results of competition enzyme experiments showed that enzyme responses to submaximal amounts of UMP and UTP were additive, whereas those to saturating concentrations of both nucleotides were not. This latter observation demonstrates that UMP and UTP stimulate the same pool of phosphoinositidase C with differing apparent affinities and suggests that the high-affinity UMP receptors do not promote enzyme activation. Thus, taken together, results of binding and enzyme studies indicate that some [ 3 H]UTP-labeled binding sites exhibit functional properties differing from those of the biological nucleotide receptors triggering phosphoinositidase C activation.
The [ 3 H]UTP-labeled binding sites uncoupled to phosphoinositidase C might correspond to those revealing high affinity for UTP for the following evidence: 1) UTP interacted with the minor class of labeled binding sites with a K D value 10 times lower than its K a value for activation of InsP s production, 2) the weak P2(Y) agonist UMP (26) bound to ampullas with the highest apparent affinity and negative cooperativity phenomena, whereas it stimulated phosphoinositidase C with a low affinity and slight positive cooperativity phenomena, 3) dTTP and CTP interacted with apparent affinities far higher than their corresponding affinities for enzyme stimulation (6), 4) uridine bound with a low affinity but did not increase InsP s production, and 5) the antagonist suramin bound with a K B value 10 times lower than its K i value for inhibition of UTP-induced phosphoinositidase C activation. So, this population of high-affinity UTP binding sites might represent either 1) nonspecific nucleotide binding proteins unrelated to P2 receptors, 2) P2(Y)-like receptors promoting their biochemical effects through phosphoinositidase C-independent pathways as shown for P2(Y) receptor-mediated phospholipase D stimulation in Madin-Darby canine kidney-D1 cells (3), 3) a desensitized form of P2(Y)-like receptors revealing high affinities for pyrimidine nucleotides as observed for acetylcholine receptors from Torpedo marmorata (15), or 4) enzymes implied in the degradation of extracellular nucleotides, but differing from the ecto-nucleotidases found in the guinea pig cochlear perilymphatic compartment that hydrolyze substrates with Michaelis constant values in the millimolar range (29) . These UTP binding sites might be clearance nucleotide receptors, as reported for atrial natriuretic peptide (ANP) binding to rat kidney clearance ANP receptors defined as opposed to biological ANP receptors triggering guanylate cyclase stimulation (21) . But these hypotheses call for additional investigations.
On these grounds, it may be postulated that the major class of moderate-affinity UTP binding sites correspond to the physiological nucleotide P2(Y)-like receptors involved in phosphoinositidase C activation processes. Finally, it should be stressed that reactive blue 2 diminished UTP-induced phosphoinositidase C activation according to competitive inhibition kinetics, whereas it acted as a pure noncompetitive inhibitor for decrease of ATP-stimulated enzyme activity (6) . This observation provides further evidence for the coexpression in frog ampulla of both purine P2Y 1 -like and pyrimidine P2(Y)-like receptors linked to phosphoinositidase C activation (6, 7) .
Perspectives
The pyrimidine nucleotide-sensitive P2(Y)-like receptors found in frog semicircular canal reveal pharmacological properties differing markedly from those of the putative P2Y 2 , P2Y 4 , and P2Y 6 receptors cloned from mammalian species (8, 9, 25, 30) or from those of any mixture of known P2Y receptor subtypes (13, 14, 32) . Thus molecular cloning experiments will be needed to further identify the P2(Y)-like receptors found in frog ampulla.
The expression of P2(Y)-like receptors in frog ampulla raises obvious questions about their cellular localization(s) and biological function(s). Physiological experiments performed in nonsensory tissues of the gerbil inner ear suggest that pyrimidine nucleotide P2(Y) receptors are involved in the regulation of K ϩ secretion (20) . So, the biological significance of the P2(Y)-like receptors found in amphibian semicircular canal remains to be defined in further electrophysiological experiments.
